메뉴 건너뛰기




Volumn 28, Issue 7, 2004, Pages 327-332

Agressive large cell lymphoma: Early assessment of therapeutic efficacy by positron emission tomography;Lymphome agressif à grandes cellules: Appréciation précoce de l'efficacité thérapeutique par la TEP au [ 18F]-FDG

Author keywords

18F FDG; Aggressive lymphoma; Early therapeutic response; PET; Survival

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

EID: 4644302099     PISSN: 09281258     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (3)

References (15)
  • 1
    • 0032784783 scopus 로고    scopus 로고
    • World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997
    • Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink H.K., Vardiman J. et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-3849.
    • (1999) J Clin Oncol , vol.17 , pp. 3835-3849
    • Harris, N.L.1    Jaffe, E.S.2    Diebold, J.3    Flandrin, G.4    Muller-Hermelink, H.K.5    Vardiman, J.6
  • 2
    • 0027444652 scopus 로고
    • The international non-Hodgkin's lymphoma prognostic factors project. A predictive model for aggressive non-Hodgkin's lymphoma
    • The international non-Hodgkin's lymphoma prognostic factors project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987-994.
    • (1993) N Engl J Med , vol.329 , pp. 987-994
  • 3
    • 0035281784 scopus 로고    scopus 로고
    • 2-(Fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial
    • Buchmann I., Reinhardt M., Elsner K., Bunjes D., Altehoefer C., Finke J. et al. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer 2001; 91: 889-899.
    • (2001) Cancer , vol.91 , pp. 889-899
    • Buchmann, I.1    Reinhardt, M.2    Elsner, K.3    Bunjes, D.4    Altehoefer, C.5    Finke, J.6
  • 5
    • 0035074636 scopus 로고    scopus 로고
    • Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease
    • Jérusalem G., Béguin Y., Fassotte M.F., Najjar F., Paulus P., Rigo P. et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica 2001; 86: 266-73.
    • (2001) Haematologica , vol.86 , pp. 266-273
    • Jérusalem, G.1    Béguin, Y.2    Fassotte, M.F.3    Najjar, F.4    Paulus, P.5    Rigo, P.6
  • 6
    • 0034909179 scopus 로고    scopus 로고
    • Effect of whole-body (18)F-FDG-PET imaging on clinical staging and management of patients with malignant lymphoma
    • Schoder H., Meta J., Yap C., Ariannejad M., Rao J., Phelps M.E. et al. Effect of whole-body (18)F-FDG-PET imaging on clinical staging and management of patients with malignant lymphoma. J Nucl Med 2001; 42: 1139-1143.
    • (2001) J Nucl Med , vol.42 , pp. 1139-1143
    • Schoder, H.1    Meta, J.2    Yap, C.3    Ariannejad, M.4    Rao, J.5    Phelps, M.E.6
  • 7
    • 0042449063 scopus 로고    scopus 로고
    • Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas
    • NCI Sponsored International Working Group
    • Cheson B.D., Horning S.J., Coiffier B., Shipp M.A., Fisher R.I., Connors J.M. et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244.
    • (1999) J Clin Oncol , vol.17 , pp. 1244
    • Cheson, B.D.1    Horning, S.J.2    Coiffier, B.3    Shipp, M.A.4    Fisher, R.I.5    Connors, J.M.6
  • 8
    • 0033566341 scopus 로고    scopus 로고
    • Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging
    • Jérusalem G., Béguin Y., Fassotte M.F., Najjar F., Paulus P., Rigo P. et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood 1999; 94: 429-433.
    • (1999) Blood , vol.94 , pp. 429-433
    • Jérusalem, G.1    Béguin, Y.2    Fassotte, M.F.3    Najjar, F.4    Paulus, P.5    Rigo, P.6
  • 9
    • 0034485716 scopus 로고    scopus 로고
    • 18-FDG-PET as a prognostic indicator in the treatment of aggressive non-Hodgkin's lymphoma-comparison with CT
    • Mikhaeel N.G., Timothy A.R., O'Doherty M.J., Hain S., Maisey M.N. 18-FDG-PET as a prognostic indicator in the treatment of aggressive non-Hodgkin's lymphoma-comparison with CT. Leuk Lymphoma 2000; 39: 543-553.
    • (2000) Leuk Lymphoma , vol.39 , pp. 543-553
    • Mikhaeel, N.G.1    Timothy, A.R.2    O'Doherty, M.J.3    Hain, S.4    Maisey, M.N.5
  • 10
    • 2642613656 scopus 로고    scopus 로고
    • Positron emission tomography in non-Hodgkin's lymphoma: Assessment of chemotherapy with fluorodeoxyglucose
    • Römer W., Hanauske A.R., Ziegler S., Thodtmann R., Weber W., Fuchs C. et al. Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. Blood 1998; 91: 4464-4471.
    • (1998) Blood , vol.91 , pp. 4464-4471
    • Römer, W.1    Hanauske, A.R.2    Ziegler, S.3    Thodtmann, R.4    Weber, W.5    Fuchs, C.6
  • 11
    • 0033624050 scopus 로고    scopus 로고
    • Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma
    • Jérusalem G., Béguin Y., Fassotte M.F., Najjar F., Paulus P., Rigo P. et al. Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma. Haematologica 2000; 85: 613-618.
    • (2000) Haematologica , vol.85 , pp. 613-618
    • Jérusalem, G.1    Béguin, Y.2    Fassotte, M.F.3    Najjar, F.4    Paulus, P.5    Rigo, P.6
  • 12
    • 0036327331 scopus 로고    scopus 로고
    • PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease
    • Kostakoglu L., Coleman M., Leonard J.P., Kuji I., Zoe H., Goldsmith S.J. PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease. J Nucl Med 2002; 43: 1018-1027.
    • (2002) J Nucl Med , vol.43 , pp. 1018-1027
    • Kostakoglu, L.1    Coleman, M.2    Leonard, J.P.3    Kuji, I.4    Zoe, H.5    Goldsmith, S.J.6
  • 13
    • 0036739436 scopus 로고    scopus 로고
    • Early restaging positron emission tomography with (18)F- fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma
    • Spaepen K., Stroobants S., Dupont P., Vandenberghe P., Thomas J., de Groot T. et al. Early restaging positron emission tomography with (18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma. Ann Oncol 2002; 13: 1356-1363.
    • (2002) Ann Oncol , vol.13 , pp. 1356-1363
    • Spaepen, K.1    Stroobants, S.2    Dupont, P.3    Vandenberghe, P.4    Thomas, J.5    De Groot, T.6
  • 14
    • 0037142053 scopus 로고    scopus 로고
    • The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
    • Rosenwald A., Wright G., Chan W.C., Connors J.M., Campo E., Fisher R.I. et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 1937-1947.
    • (2002) N Engl J Med , vol.346 , pp. 1937-1947
    • Rosenwald, A.1    Wright, G.2    Chan, W.C.3    Connors, J.M.4    Campo, E.5    Fisher, R.I.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.